Science Explorer Back to mapMap
Discussion
Researcher · Guangdong Medical College · China

Lingpin Pang

Lingpin Pang publishes mostly in Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Physiology, on topics such as Pulmonary Hypertension Research and Treatments, Heart Failure Treatment and Management and Venous Thromboembolism Diagnosis and Management.

ORCID 0000-0002-7389-1727 OpenAlex
World rank
#4,969,885
of 7,710,434 ranked researchers
Rank in China
#743,345
of 978,568
Works
17
Citations
39
Citations per work
2.3
h-index
4
i10-index 1Top 90% in Cardiology and Cardiovascular Medicine
Lingpin Pang

What does Lingpin Pang research?

Lingpin Pang's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 11 works · 62.0% of their workMedicine: 11 works · 62.0% of their workCardiology and Cardiovascular Medicine: 4 works · 26.0% of their workPulmonary and Respiratory Medicine: 3 works · 16.0% of their workPhysiology: 1 works · 8.0% of their workComplementary and alternative medicine: 1 works · 6.0% of their workEpidemiology: 1 works · 6.0% of their workEverything else: 5 works · 32.0% of their workLife Sciences: 1 works · 6.0% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 6.0% of their workGenetics: 1 works · 6.0% of their workTHEIR WORKLingpin Pang17works
Life Sciences6%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1162.0%
  2. Everything else532.0%
    1. Biochemistry, Genetics and Molecular Biology16.0%
  1. 1Cardiology and Cardiovascular Medicine26% of their works
  2. 2Pulmonary and Respiratory Medicine16% of their works
  3. 3Physiology8% of their works
  4. 4Complementary and alternative medicine6% of their works
  5. 5Epidemiology6% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Lingpin Pang's research?

The keywords of their largest research topics: Epidemiology, Echocardiography, Cardiovascular Disease, Diagnosis, Guidelines, Heart Failure, Pulmonary Hypertension and Right Heart Assessment.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Epidemiology83 topics
  2. Echocardiography72 topics
  3. Cardiovascular Disease62 topics
  4. Diagnosis62 topics
  5. Guidelines52 topics
  6. Heart Failure52 topics
  7. Pulmonary Hypertension51 topic
  8. Right Heart Assessment51 topic
  9. Risk Factors52 topics
  10. Antithrombotic Therapy31 topic
  11. B-Type Natriuretic Peptide31 topic
  12. Hospital Readmission31 topic
  13. Obstructive Sleep Apnea31 topic
  14. Sleep-Disordered Breathing31 topic
  15. Venous Thromboembolism31 topic
  16. Anticoagulant Therapy21 topic
  17. Atrial Fibrillation21 topic
  18. Cardiovascular Health21 topic
  19. Chamber Quantification21 topic
  20. Diastolic Function21 topic
  21. Genetic Variation21 topic
  22. Genome-Wide Association21 topic
  23. Ideal Cardiovascular Health21 topic

Where does Lingpin Pang work?

Lingpin Pang's main affiliation in the publication record is Guangdong Medical College, China.

How many publications and citations does Lingpin Pang have?

OpenAlex counts 17 works and 39 citations for Lingpin Pang, an h-index of 4, ranking #4,969,885 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lingpin Pang. Posts are plain text and can be reported.